Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Neurotoxicology
|
September 24, 1998
Genetic polymorphisms in Parkinson's disease
H Checkoway, F M Farin, P Costa-Mallen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 16, 2000
Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism
P Costa-Mallen, L G Costa, T Smith-Weller, et al.
Neurology
|
May 22, 1998
A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease
H Checkoway, G M Franklin, P Costa-Mallen, et al.
Growth Factors (Chur, Switzerland)
|
August 25, 2001
Modulation of DNA synthesis by muscarinic cholinergic receptors
L G Costa, M Guizzetti, J Oberdoerster, et al.
Neuroscience Letters
|
January 22, 2000
The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease
P Costa-Mallen, H Checkoway, M Fishel, et al.
Environmental Health Perspectives
|
March 12, 1998
Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers
B H Alexander, H Checkoway, P Costa-Mallen, et al.
Neurology
|
May 16, 2002
MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD
M A Hernán, H Checkoway, R O'Brien, et al.
Neurotoxicology
|
October 7, 2000
Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson's disease
S C Kirchner, S E Hallagan, F M Farin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 18, 2003
Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease
S N Kelada, P Costa-Mallen, H Checkoway, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Neurotoxicology
|
September 24, 1998
Genetic polymorphisms in Parkinson's disease
H Checkoway, F M Farin, P Costa-Mallen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 16, 2000
Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism
P Costa-Mallen, L G Costa, T Smith-Weller, et al.
Neurology
|
May 22, 1998
A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease
H Checkoway, G M Franklin, P Costa-Mallen, et al.
Growth Factors (Chur, Switzerland)
|
August 25, 2001
Modulation of DNA synthesis by muscarinic cholinergic receptors
L G Costa, M Guizzetti, J Oberdoerster, et al.
Neuroscience Letters
|
January 22, 2000
The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease
P Costa-Mallen, H Checkoway, M Fishel, et al.
Environmental Health Perspectives
|
March 12, 1998
Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers
B H Alexander, H Checkoway, P Costa-Mallen, et al.
Neurology
|
May 16, 2002
MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD
M A Hernán, H Checkoway, R O'Brien, et al.
Neurotoxicology
|
October 7, 2000
Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson's disease
S C Kirchner, S E Hallagan, F M Farin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 18, 2003
Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease
S N Kelada, P Costa-Mallen, H Checkoway, et al.
Page
of 1